Testing SHR-7787 for advanced solid tumors
Part of Cancer clinical trials.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer has come back after treatment or spread, and can't be removed by surgery.
- You have at least one tumor that can be seen and measured on a scan.
- You are able to be up and about (like doing light housework or office work) – doctors call this ECOG 0 or 1.
- Your organs (like liver, kidneys, bone marrow) are working well enough.
- You have not had cancer treatment in the last 5 years for a different cancer (except for some cured types).
- You do not have active brain metastases, uncontrolled infections, heart problems, or autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.
This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests an experimental drug called SHR-9803 for people with advanced solid tumors. It aims to see if the drug is safe and works against cancer.
This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.
This trial tests a new drug called SHR-4849 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and effective, and may offer a new option for those who have limited choices.
This trial tests a new drug called SHR-9839 combined with other cancer treatments for people with advanced solid tumors, including a certain type of lung cancer. The goal is to see if the combination is safe and effective against the cancer.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.